Discussion: Statistical Perspective

Enas GG . Making decisions about safety in clinical trials — the case for inferential statistics. Drug Inf J. 1991;25: 439–446.

Huster WJ . Clinical trial adverse events: The case for descriptive techniques. Drug lnf J. 1991;25: 447–456.

Cutler SJ Ederer F. Maximum utilization of the life table method in analyzing survival. Journal of Chronic Disease. 1958;6: 699–712.

O'Neill RT . Assessment of safety. In: Peace KE , ed. Biopharmaceutical Statistics for Drug Development. New York: Marcel Dekker, Inc.; 1988: 543–604.

Cox DR . Regression models and life tables (with discussion). Journal of the Royal Statistical Society B. 1972;34: 187–220.

Edwards SE Koch GG Sollecito WA Peace KE . Summarization, analysis and monitoring of adverse events. In: Peace KE , ed. Statistical Issues in Drug Research and Development. New York: Marcel Dekker, Inc.; 1990: 19–170.

Hedges L Olkin I. Statistical Methods for Meta-analysis. New York: Academic Press; 1985.

DerSimonian R Laird N. Meta–analysis in clinical trials. Controlled Clinical Trials. 1986;7: 177–188.

Kleinbaum DG Kupper LL Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, CA: Lifetime Learning Publications; 1982.

Fleiss JL . Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley & Sons; 1981.

Bissette J Carr G Koch G Adams KF Sheps DS . Analysis of (events/time at risk) ratios from two–period crossover studies. Proceedings of the Biopharmaceutical Section. Washington, DC: American Statistical Association; 1986: 104–9.